July 5, 2016

Tony winner Kelli O’Hara to headline 21st annual
索尔克音乐会

索尔克新闻


Tony winner Kelli O’Hara to headline 21st annual Symphony at Salk

LA JOLLA—The Salk Institute will celebrate 21 years of Symphony at Salk, its signature concert under the stars, with Broadway luminary Kelli O’Hara and the incomparable San Diego Symphony led by guest conductor Maestro Thomas Wilkins on Saturday, August 20.

O'Hara, Kelli - photo
Kelli O’Hara

The gala evening concert on the courtyard of the Louis Kahn-designed Institute will showcase O’Hara performing her Broadway showstoppers and selections from the Great American Songbook. Her portrayal of Anna Leonowens in the critically acclaimed revival of The King and I garnered her the 2015 Tony Award for Best Leading Actress in a Musical. Since her Broadway debut in Jekyll & Hyde in 2000, she has moved from one critical and commercial success to another, earning numerous Tony, Drama Desk, Drama League and Outer Critics Circle nominations. A recent New York Times review of her operatic turn in Dido and Aeneas raved, “Ms. O’Hara can sign a Rodgers and Hammerstein number as if she were talking to you, while still bringing exquisite sound to her phrases.”

Individual tickets for Symphony at Salk are $300 and include a champagne reception and gourmet dinner. All proceeds support the Institute’s wide-ranging scientific inquiries that have yielded more than 50 years of life-changing discoveries, directly influencing areas as diverse as cancer, Alzheimer’s Parkinson’s, metabolic diseases, ALS, schizophrenia, autism, spinal cord injuries, crop yields and world hunger. Proceeds also support Salk’s award-winning educational outreach programs that have helped generations of students discover their passion for research and explore careers in science.

Tickets can be purchased online at www.salk.edu/symphony. For more information, call (858) 597-0657.

更多信息

宣传办公室
电话:(858) 453-4100
press@salk.edu

萨尔克生物学研究所

萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.